List view / Grid view
2 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
22 June 2018 | By European Pharmaceutical Review
A study has found a novel mechanism underlying stable, durable blood sugar control...
6 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
First European filing acceptance of a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor in type-1 diabetes...
14 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A drug-carrying microsphere within a cell-bearing microcapsule could be the key to transplanting insulin-secreting pig pancreas cells into human patients...
3 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have devised a method for implanting islet cells into a patient that may control the management of type 1 diabetes...
12 December 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes...
14 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
3 April 2017 | By Dr David Pugh, IDTechEx
The latest 2017 pipelines explores new emerging methods of glucose monitoring, analysing these technologies in the new report from IDTechEx Research...
5 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) are pleased to announce that less than two years after forming a strategic alliance aimed at bringing new treatments to patients with diabetes, the companies will present 30 abstracts across three compounds and three classes of medicine at the 72nd American…
Follow: